A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae

Journal of General Virology

Volumn 80, Issue 10, 1999, Pages 2751-2755

  Tscharke, David C ^a   Smith, Geoffrey L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; EAR; FEMALE; HUMORAL IMMUNITY; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS IMMUNITY; VIRUS PATHOGENESIS;

EID: 0032882443     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-10-2751     Document Type: Article

References (17)

1. Andrew, M. E., Coupar, B. E. & Boyle, D. B. (1989). Humoral and cell-mediated immune responses to recombinant vaccinia viruses in mice. Immunology and Cell Biology 67, 331-337.
2. Antolne, G., Scheiflinger, F., Domer, F. & Falkner, F. G. (1998). The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244, 365-396.
3. Blanchard, T. J., Alcamí, A., Andrea, P. & Smith, G. L. (1998). Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine. Journal of General Virology 79, 1159-1167.
4. Briody, B. (1959). Response of mice to ectromelia and vaccinia viruses. Bacteriological Reviews 23, 61-95.
5. Buller, R. M. (1985). The BALB/c mouse as a model to study orthopoxviruses. Current Topics in Microbiology and Immunology 122, 148-153.
6. Buller, R. M., Chakrabarti, S., Moss, B. & Fredrickson, T. (1988). Cell proliferative response to vaccinia virus is mediated by VGF. Virology 164, 182-192.
7. Hanson, C. V., Riggs, J. L. & Lennette, E. H. (1978). Photochemical inactivation of DNA and RNA viruses by psoralen derivatives. Journal of General Virology 40, 345-358.
8. Hill, T. J., Field, H. J. & Blyth, W. A. (1975). Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease. Journal of General Virology 28, 341-353.
9. Ikeda, S., Tominaga, T. & Nishimura, C. (1991). Thy 1 + asialo GM1 + dendritic epidermal cells in skin defense mechanisms of vaccinia virus-infected mice. Archives of Virology 117, 207-218.
10. Lee, M. S., Roos, J. M., McGuigan, L. C., Smith, K. A., Cormier, N., Cohen, L. K., Roberts, B. E. & Payne, L. G. (1992). Molecular attenuation of vaccinia virus: mutant generation and animal characterization. Journal of Virology 66, 2617-2630.
11. Miyahira, Y., Murata, K., Rodriguez, D., Rodriguez, J. R., Esteban, M., Rodrigues, M. M. & Zavala, F. (1995). Quantification of antigen specific CD8 + T cells using an ELISPOT assay. Journal of Immunological Methods 181, 45-54.
12. Moorhead, J. W., Clayton, G. H., Smith, R. L. & Schaack, J. (1999). A replication-incompetent adenovirus vector with the preterminal protein gene deleted efficiently transduces mouse ears. Journal of Virology 73, 1046-1053.
13. Nelson, J. B. (1938). The behaviour of poxviruses in the respiratory tract. I. The response of mice to the nasal instillation of vaccinia virus. Journal of Experimental Medicine 68, 401-412.
14. Schneider, J., Gilbert, S. C., Blanchard, T. J., Hanke, T., Robson, K. J., Hannan, C. M., Becker, M., Sinden, R., Smith, G. L. & Hill, A. V. (1998). Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nature Medicine 4, 397-402.
15. Smith, G. L., Symons, J. A., Khanna, A., Vanderplasschen, A. & Alcamí, A. (1997). Vaccinia virus immune evasion. Immunological Reviews 159, 137-154.
16. Tartaglia, J., Perkus, M. E., Taylor, J., Norton, E. K., Audonnet, J. C., Cox, W. I., Davis, S. W., van der Hoeven, J., Meignier, B., Riviere, M. and others (1992). NYVAC: a highly attenuated strain of vaccinia virus. Virology 188, 217-232.
17. Turner, G. S. (1967). Respiratory infection of mice with vaccinia virus. Journal of General Virology 1, 399-402.